Paper33145451
Evaluation of efficacy and safety of a novel lipogel containing diclofenac: A randomized, placebo controlled, double-blind clinical trial in patients with signs and symptoms of osteoarthritis.
Bhatia A and 4 others. Contemp Clin Trials Commun, 2020. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Evaluation of efficacy and safety of a novel lipogel containing diclofenac: A randomized, placebo controlled, double-blind clinical trial in patients with signs and symptoms of osteoarthritis. Papers, record 33145451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33145451
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Evaluation of efficacy and safety of a novel lipogel containing diclofenac: A randomized, placebo controlled, double-blind clinical trial in patients with signs and symptoms of osteoarthritis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31334187 | A cross-sectional study to screen community health volunteers for hip/knee-osteoarthritis and osteoporosis. | J Family Med Prim Care | 2019 | https://conductscience.org/library/papers/31334187 | PubMed |
| 2 | 12897215 | Osteoarthritis. | Postgrad Med J | 2003 | https://conductscience.org/library/papers/12897215 | PubMed |
| 3 | 25457327 | Total knee replacement in acute and chronic traumatic events. | Injury | 2014 | https://conductscience.org/library/papers/25457327 | PubMed |
| 4 | 16086839 | Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886]. | BMC Musculoskelet Disord | 2005 | https://conductscience.org/library/papers/16086839 | PubMed |
| 5 | 24692832 | Comparative assessment of the effectiveness and tolerability of lornoxicam 8 mg BID and diclofenac 50 mg TID in adult indian patients with osteoarthritis of the hip or knee: A 4-week, double-blind, randomized, comparative, multicenter study. | Curr Ther Res Clin Exp | 2009 | https://conductscience.org/library/papers/24692832 | PubMed |
| 6 | 16331769 | Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee. | J Rheumatol | 2005 | https://conductscience.org/library/papers/16331769 | PubMed |
| 7 | 21811391 | Diclofenac topical solution compared with oral diclofenac: a pooled safety analysis. | J Pain Res | 2011 | https://conductscience.org/library/papers/21811391 | PubMed |
| 8 | 19850095 | Nanotechnology and the transdermal route: A state of the art review and critical appraisal. | J Control Release | 2010 | https://conductscience.org/library/papers/19850095 | PubMed |
| 9 | 15020333 | The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. | Ann Rheum Dis | 2004 | https://conductscience.org/library/papers/15020333 | PubMed |
| 10 | 15608303 | Using patients' and rheumatologists' opinions to specify a short form of the WOMAC function subscale. | Ann Rheum Dis | 2005 | https://conductscience.org/library/papers/15608303 | PubMed |
| 11 | 11014340 | Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. | Arthritis Rheum | 2000 | https://conductscience.org/library/papers/11014340 | PubMed |
| 12 | 20615093 | Design and evaluation of flexible membrane vesicles (FMVs) for enhanced topical delivery of capsaicin. | J Drug Target | 2011 | https://conductscience.org/library/papers/20615093 | PubMed |
| 13 | 17363401 | Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial. | Ann Rheum Dis | 2007 | https://conductscience.org/library/papers/17363401 | PubMed |
| 14 | 32086778 | Topical Diclofenac, an Efficacious Treatment for Osteoarthritis: A Narrative Review. | Rheumatol Ther | 2020 | https://conductscience.org/library/papers/32086778 | PubMed |
| 15 | 19817509 | The economic burden of osteoarthritis. | Am J Manag Care | 2009 | https://conductscience.org/library/papers/19817509 | PubMed |
| 16 | 16808554 | Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk. | Drug Saf | 2006 | https://conductscience.org/library/papers/16808554 | PubMed |
| 17 | 26720629 | Nonsteroidal Anti-inflammatory Drugs and Risk of Incident Heart Failure: A Systematic Review and Meta-analysis of Observational Studies. | Clin Cardiol | 2016 | https://conductscience.org/library/papers/26720629 | PubMed |
| 18 | 27755265 | Measures for Pain and Function Assessments for Patients With Osteoarthritis. | J Am Acad Orthop Surg | 2016 | https://conductscience.org/library/papers/27755265 | PubMed |
| 19 | 15742450 | What WOMAC pain score should make a patient eligible for a trial in knee osteoarthritis? | J Rheumatol | 2005 | https://conductscience.org/library/papers/15742450 | PubMed |
| 20 | 24393558 | Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. | J Pharm Pharm Sci | 2013 | https://conductscience.org/library/papers/24393558 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41795066 | Advancement on localized targeting via intra-articular administration of lipid-based vesicular nanoparticles for osteoarthritis management. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/41795066 | PubMed |
| 36836078 | Multidisciplinary Guidelines for the Rational Use of Topical Non-Steroidal Anti-Inflammatory Drugs for Musculoskeletal Pain (2022). | J Clin Med | 2023 | https://conductscience.org/library/papers/36836078 | PubMed |
| 36031671 | Exploration of novel drug delivery systems in topical management of osteoarthritis. | Drug Deliv Transl Res | 2023 | https://conductscience.org/library/papers/36031671 | PubMed |
| 36003519 | Therapeutic potential of nanotechnology-based approaches in osteoarthritis. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36003519 | PubMed |
| 34951922 | New developments in osteoarthritis pharmacological therapies. | Rheumatology (Oxford) | 2021 | https://conductscience.org/library/papers/34951922 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33145451
GET https://conductscience.org/api/papers/v1/33145451/references?page=2